The mitochondrial DNA 4,977-bp deletion and its implication in copy number alteration in colorectal cancer

BMC Medical Genetics

Volumn 12, Issue , 2011, Pages

  Chen, Tao ^a   He, Jing ^a   Shen, Lijun ^a   Fang, Hezhi ^a   Nie, Hezhongrong ^a   Jin, Tao ^a   Wei, Xiaosong ^a   Xin, Yijuan ^a   Jiang, Yulin ^a   Li, Hongzhi ^a   Chen, Guorong ^a   Lu, Jianxin ^a   Bai, Yidong ^a,b  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; DNA;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CHINA; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA CONTENT; GENE DELETION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; REAL TIME POLYMERASE CHAIN REACTION; COLORECTAL TUMOR; FEMALE; GENETICS; INCIDENCE; MALE; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CHINA; COLORECTAL NEOPLASMS; DNA COPY NUMBER VARIATIONS; DNA, MITOCHONDRIAL; DNA, NEOPLASM; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; SEQUENCE DELETION;

EID: 78651281751     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-12-8     Document Type: Article

References (43)

1. Jemal A, et al. Cancer statistics, 2009. CA Cancer J Clin 2009, 59(4):225-49. 10.3322/caac.20006, 19474385.
2. Sung JJ, et al. Asia Pacific consensus recommendations for colorectal cancer screening. Gut 2008, 57(8):1166-76. 10.1136/gut.2007.146316, 18628378.
3. Lei T, et al. Prevalence trend of colorectal cancer in 10 cities and counties in China from 1988 to 2002. Zhonghua Zhong Liu Za Zhi 2009, 31(6):428-33.
4. Lichtenstein P, et al. Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000, 343(2):78-85. 10.1056/NEJM200007133430201, 10891514.
5. Czene K, Lichtenstein P, Hemminki K. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int J Cancer 2002, 99(2):260-6. 10.1002/ijc.10332, 11979442.
6. Dionigi G, et al. Genetic alteration in hereditary colorectal cancer. Surg Oncol 2007, 16(Suppl 1):S11-5. 10.1016/j.suronc.2007.10.020, 18023570.
7. Walther A, et al. Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 2009, 9(7):489-99. 10.1038/nrc2645, 19536109.
8. Wallace DC. Mitochondria as chi. Genetics 2008, 179(2):727-35. 10.1534/genetics.104.91769, 2429869, 18558648.
9. Fang H, et al. Cancer type-specific modulation of mitochondrial haplogroups in breast, colorectal and thyroid cancer. BMC Cancer 2010, 10:421-30. 10.1186/1471-2407-10-421, 2933623, 20704735.
10. Warburg O. On respiratory impairment in cancer cells. Science 1956, 124(3215):269-70.
11. Schon EA. Mitochondrial genetics and disease. Trends Biochem Sci 2000, 25(11):555-60. 10.1016/S0968-0004(00)01688-1, 11084368.
12. Schon EA, Bonilla E, DiMauro S. Mitochondrial DNA mutations and pathogenesis. J Bioenerg Biomembr 1997, 29(2):131-49. 10.1023/A:1022685929755, 9239539.
13. Wallace DC, et al. Mitochondrial DNA mutations in human degenerative diseases and aging. Biochim Biophys Acta 1995, 1271(1):141-51.
14. Shen L, et al. Evaluating mitochondrial DNA in patients with breast cancer and benign breast disease. J Cancer Res Clin Oncol
15. Clay Montier LL, Deng JJ, Bai Y. Number matters: control of mammalian mitochondrial DNA copy number. J Genet Genomics 2009, 36(3):125-31. 10.1016/S1673-8527(08)60099-5, 19302968.
16. Brandon M, Baldi P, Wallace DC. Mitochondrial mutations in cancer. Oncogene 2006, 25(34):4647-62. 10.1038/sj.onc.1209607, 16892079.
17. Chatterjee A, Mambo E, Sidransky D. Mitochondrial DNA mutations in human cancer. Oncogene 2006, 25(34):4663-74. 10.1038/sj.onc.1209604, 16892080.
18. Shen L, et al. Evaluating mitochondrial DNA in cancer occurrence and development. Ann N Y Acad Sci 1201:26-33. 10.1111/j.1749-6632.2010.05635.x, 20649535.
19. Lezza AM, et al. Mitochondrial DNA 4977 bp deletion and OH8dG levels correlate in the brain of aged subjects but not Alzheimer's disease patients. Faseb J 1999, 13(9):1083-8.
20. Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988, 331(6158):717-9. 10.1038/331717a0, 2830540.
21. Zeviani M, et al. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 1988, 38(9):1339-46.
22. Taylor RW, Turnbull DM. Mitochondrial DNA mutations in human disease. Nat Rev Genet 2005, 6(5):389-402. 10.1038/nrg1606, 1762815, 15861210.
23. Meissner C, et al. The 4977 bp deletion of mitochondrial DNA in human skeletal muscle, heart and different areas of the brain: a useful biomarker or more?. Exp Gerontol 2008, 43(7):645-52. 10.1016/j.exger.2008.03.004, 18439778.
24. Lu J, Sharma LK, Bai Y. Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis. Cell Res 2009, 19(7):802-15. 10.1038/cr.2009.69, 19532122.
25. Polyak K, et al. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet 1998, 20(3):291-3. 10.1038/3108, 9806551.
26. Lievre A, et al. Clinical value of mitochondrial mutations in colorectal cancer. J Clin Oncol 2005, 23(15):3517-25. 10.1200/JCO.2005.07.044, 15908662.
27. Ding Z, et al. Analysis of mitochondrial DNA mutations in D-loop region in thyroid lesions. Biochim Biophys Acta 1800(3):271-4.
28. Lee HC, Wei YH. Mitochondrial DNA instability and metabolic shift in human cancers. Int J Mol Sci 2009, 10(2):674-701. 10.3390/ijms10020674, 2660656, 19333428.
29. Dani SU, Dani MA, Simpson AJ. The common mitochondrial DNA deletion deltamtDNA(4977): shedding new light to the concept of a tumor suppressor mutation. Med Hypotheses 2003, 61(1):60-3. 10.1016/S0306-9877(03)00105-1, 12781642.
30. Park JS, et al. A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis. Hum Mol Genet 2009, 18(9):1578-89. 10.1093/hmg/ddp069, 2733816, 19208652.
31. Butow RA, Avadhani NG. Mitochondrial signaling: the retrograde response. Mol Cell 2004, 14(1):1-15. 10.1016/S1097-2765(04)00179-0, 15068799.
32. Xing E. Mitochondrial DNA Content: Its Genetic Heritability and Association With Renal Cell Carcinoma. J. Natl. Cancer Inst 2008, 100(15):1104-1112. 10.1093/jnci/djn213, 2720693, 18664653.
33. Wu CW, et al. Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer. Genes Chromosomes Cancer 2005, 44(1):19-28. 10.1002/gcc.20213, 15892105.
34. Mambo E, et al. Tumor-specific changes in mtDNA content in human cancer. Int J Cancer 2005, 116(6):920-4. 10.1002/ijc.21110, 15856456.
35. Yin PH, et al. Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma. Br J Cancer 2004, 90(12):2390-6. 2409531, 15150555.
36. Heddi A, et al. Coordinate expression of nuclear and mitochondrial genes involved in energy production in carcinoma and oncocytoma. Biochim Biophys Acta 1996, 1316(3):203-9.
37. Kim MM, et al. Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions. Clin Cancer Res 2004, 10(24):8512-5. 10.1158/1078-0432.CCR-04-0734, 15623632.
38. Wang Y, et al. The increase of mitochondrial DNA content in endometrial adenocarcinoma cells: a quantitative study using laser-captured microdissected tissues. Gynecol Oncol 2005, 98(1):104-10. 10.1016/j.ygyno.2005.04.015, 15921730.
39. Wang Y, et al. Association of decreased mitochondrial DNA content with ovarian cancer progression. Br J Cancer 2006, 95(8):1087-91. 10.1038/sj.bjc.6603377, 2360719, 17047655.
40. Lee HC, et al. Mitochondrial genome instability and mtDNA depletion in human cancers. Ann N Y Acad Sci 2005, 1042:109-22. 10.1196/annals.1338.011, 15965052.
41. Shoffner JM, et al. Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy. Proc Natl Acad Sci USA 1989, 86(20):7952-6. 10.1073/pnas.86.20.7952, 298190, 2554297.
42. Porteous WK, et al. Bioenergetic consequences of accumulating the common 4977-bp mitochondrial DNA deletion. Eur J Biochem 1998, 257(1):192-201. 10.1046/j.1432-1327.1998.2570192.x, 9799119.
43. Peng TI, et al. Visualizing common deletion of mitochondrial DNA-augmented mitochondrial reactive oxygen species generation and apoptosis upon oxidative stress. Biochim Biophys Acta 2006, 1762(2):241-55.